To include your compound in the COVID-19 Resource Center, submit it here.

Accounting for microbial PK

Predicting the microbiome’s contribution to drug metabolism

A Yale University team has created a mathematical model that predicts how the gut microbiome contributes to drug metabolism, offering companies a way to factor microbiome-driven variability between patients into dosing, toxicity and PK studies.

Drug developers have historically ignored the role of the microbiome in

Read the full 462 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers